Position in TMO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,877,806
+$83,950 QoQ
Shares Held
5,740
+1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,029
of 2,602 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIDELIS CAPITAL PARTNERS, LLC holds $5,170,375 across 5 Diagnostics & Research names. TMO ranks #1 (55.7% of the industry book) .
All Filings in TMO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,877,806 | 5,740 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,793,856 | 5,684 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,530,009 | 6,092 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,678,280 | 5,522 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,651,844 | 4,074 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,125,249 | 4,271 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,895,197 | 3,643 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,961,485 | 3,171 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,739,738 | 3,146 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,941,822 | 3,341 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,666,149 | 3,139 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,459,288 | 2,883 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,370,115 | 2,626 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,436,890 | 2,493 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $735,171 | 1,335 | Shares | Sole | 2023-01-20 | |
| No filing history on record for this holder in this stock. | ||||||